Ara h 1 and Ara h 6 Sensitization Causes Clinical Peanut Allergy in Ara h 2-Negative Individuals.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Vidarsdóttir, Anna Gudrun
Ludviksson, Bjorn Runar
Lund, Sigrun Helga
Jensen, Anders B
Sigurdardottir, Sigurveig T
MetadataShow full item record
CitationAra h 1 and Ara h 6 Sensitization Causes Clinical Peanut Allergy in Ara h 2-Negative Individuals. 2019, 178(1):66-75 Int Arch Allergy Immunol
AbstractOf the major peanut allergens, sensitivity to Ara h 2 has the highest prediction for clinical allergy. In this study, we evaluated sensitization to peanut components in Iceland and related Ara h 2-negative sensitization to clinical allergy. Ara h 1, Ara h 2, Ara h 3, Ara h 8, and Bet v 1 IgEs were measured (ImmunoCAP) in 220 peanut IgE (Pn-IgE)-positive serum samples. Ara h 2 IgE-negative individuals were invited to an open peanut challenge and evaluated for Ara h 6 and 9 sensitization (ISAC microarray). The Ara h 2 IgE-negative group (52.3%, 115/220) was older (p = 0.04) and more likely to have a history of pollen allergy than the Ara h 2-positive group (p < 0.001). Of the Ara h 2-negative participants, 24.3% were already consuming peanuts and 38.3% were unavailable. Of the 43 who underwent an open peanut challenge, 79% were negative, 14% were positive, and 7% were inconclusive. Those who reacted to peanuts had a higher Ara h 1 IgE than that of the tolerant participants, and 3 were positive to Ara h 6 IgE, and 2 of those subjects were monosensitized. Ara h 8 may have caused a positive reaction, while Ara h 9 did not. Half of the peanut-sensitized individuals in Iceland were not sensitized to the major allergen Ara h 2. Ara h 1, Ara h 3, and Ara h 6 sensitizations resulted in a positive open peanut challenge and they are therefore clinically important for individuals with a peanut allergy in Iceland.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- Influence of age on IgE response in peanut-allergic children and adolescents from the Mediterranean area.
- Authors: Garcia-Blanca A, Aranda A, Blanca-Lopez N, Perez D, Gomez F, Mayorga C, Torres MJ, Diaz-Perales A, Perkins JR, Villalba M, Blanca M, Canto G
- Issue date: 2015 Sep
- IgE, but not IgG4, antibodies to Ara h 2 distinguish peanut allergy from asymptomatic peanut sensitization.
- Authors: Hong X, Caruso D, Kumar R, Liu R, Liu X, Wang G, Pongracic JA, Wang X
- Issue date: 2012 Dec
- Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy.
- Authors: Ackerbauer D, Bublin M, Radauer C, Varga EM, Hafner C, Ebner C, Szépfalusi Z, Fröschl R, Hoffmann-Sommergruber K, Eiwegger T, Breiteneder H
- Issue date: 2015
- Utility of specific IgE to Ara h 6 in peanut allergy diagnosis.
- Authors: Pedrosa M, Boyano-Martínez T, García-Ara C, Caballero T, Quirce S
- Issue date: 2015 Aug
- Component-resolved diagnostics for the evaluation of peanut allergy in a low-prevalence area.
- Authors: Suratannon N, Ngamphaiboon J, Wongpiyabovorn J, Puripokai P, Chatchatee P
- Issue date: 2013 Nov